Dutch authorities have completed validation of Solvay Biologicals cell-based production facility which the company will use to meet growing worldwide demand for influenza vaccines.
Sanofi-Aventis had a €5bn ($6.6bn) bid for Solvay’s pharma business rejected, according to media reports, but several other companies are believed to be interested in the Belgian firm.
Two months after the European Union (EU) released antitrust findings the FTC is suing Solvay Pharmaceuticals and two other companies for illegally agreeing to a delay generic’s release.
Solvay's first Chinese plant for a key chemical disinfectant is now
fully operational, serving the growing Chinese market and spreading
the international chemical group's global reach ever further.
Solvay today announced plans to increase production of ultra-pure
soda ash at it Dombasle, France, site to meet the growing demand in
the pharmaceutical industry.
Solvay's Epicerol process for manufacturing the chemical
intermediate epichlorohydrin from glycerine won the Belgian company
the 2007 Glycerine Innovation Award at the Annual Meeting and Expo
of the American Oil Chemists'...
Solvay Pharmaceuticals has sold two of its manufacturing facilities
that it no longer considers as core. The new owners will now act as
a contract manufacturer for Solvay, the company announced today.
Belgian chemicals company Solvay is planning to expand its
production of sodium bicarbonate to improve supplies into the
European market, reports Phil Taylor.
Belgian company Solvay is to buy Fournier Pharma for up to €1.6bn
in a move that ties into the group's long-term strategy to boost
its activities in the pharmaceuticals sector, reports Phil
Taylor.
Solvay Chemicals has said that it will increase off-list prices for
all grades of hydrogen peroxide (H2O2) in North America from 15
September in the face of escalating demand.
Solvay has doubled the output of hydrogen peroxide (H2O2) at its
Solvay Interox industrial pilot plant in Povoa, Portugal, using a
new high-yield process.